Authors

• Lucy Morgan (ORCID: https://orcid.org/0000-0001-6389-1953)
• Paola Castellani
• Francesco Blasi (ORCID: https://orcid.org/0000-0002-2285-9970)
• Kevin L. Winthrop (ORCID: https://orcid.org/0000-0002-3892-6947)
• Rachel Thomson (ORCID: https://orcid.org/0000-0003-0686-171X)
• Michal Shteinberg (ORCID: https://orcid.org/0000-0002-0432-3398)
• Oriol Sibila (ORCID: https://orcid.org/0000-0002-4833-6713)
• ALAN ROBERT BARKER (ORCID: https://orcid.org/0000-0001-8610-5417)
• Charles Haworth (ORCID: https://orcid.org/0000-0001-7126-2874)
• Felix C. Ringshausen (ORCID: https://orcid.org/0000-0001-9084-4968)
• Katerina Dimakou (ORCID: https://orcid.org/0000-0001-7457-4611)
• James Duncan Chalmers (ORCID: https://orcid.org/0000-0001-5514-7868)
• Federica Pontenani
• Kevin J. Carroll
• Anne E. O’Donnell (ORCID: https://orcid.org/0009-0006-8066-3518)

Institutions

• Oregon Health & Science University (US)
• Georgetown University (US)
• University of Cambridge (GB)
• Royal Papworth Hospital (GB)
• Georgetown University Medical Center (US)
• Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
• Central Statistics Office (IE)
• Zambon (Italy) (IT)
• Sotiria General Hospital (GR)

Publication Details

Journal

The Lancet Respiratory Medicine

Published

2024-09-10

DOI

https://doi.org/10.1016/s2213-2600(24)00225-x

Citations

20

Primary Topic

Cystic Fibrosis Research Advances

Type

article

Field-Weighted Citation Impact

8.38

Funders

• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Gilead Sciences
• University of Dundee
• Metro South Health
• Insmed
• Gallipoli Medical Research Foundation
• Deutsches Zentrum für Lungenforschung
• Grifols